The Pharma Data

NOVEMBER 25, 2020

2016 to 2019 Saw Increase in Prepregnancy Obesity in U.S. 25, 2020 — From 2016 to 2019, there was an increase in prepregnancy obesity in the United States, according to a November data brief published by the U.S. The researchers observed an increase in prepregnancy obesity in the United States, from 26.1 Professional.

Disease 52

Disease Research 52

LifeSciVC

MAY 14, 2025

Merck, Bristol-Myers Squibb, Amgen, Eli Lilly, and Gilead have all conducted microgravity research in orbit. With respect to the latter, Mercks microgravity research on Keytruda is an informative case study. Despite the progress made, microgravity research projects to date have been exploratory, small-scale one-offs.

Science 99

Science Production Research Drugs 99

Drug Target Review

SEPTEMBER 21, 2023

Introduction I clearly remember an incident as a researcher, which kept happening, from my undergraduate research up till now. Summary of research The undergraduate study concentrated on the potential adulticidal effects of oral analgesics (acetaminophen, aspirin, and ibuprofen) on Onchocerca volvulus.

Drugs 105

Drugs Treatment Disease Research 105

NIH Director's Blog: Drug Development

FEBRUARY 27, 2018

Credit: National Institute of Allergy and Infectious Diseases, NIH A major part of NIH’s mission is to support basic research that generates fundamental knowledge about the nature and behavior of living systems. As outlined in the paper, the researchers first identified all new molecular entities (NMEs) approved by the FDA from 2010 to 2016.

Research 52

Research Science FDA Pharmaceutical Companies 52

KIF1A

MARCH 2, 2024

Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Studies like SPARK highlight the importance of human data in accelerating patient-facing research. Want to learn more about translational research?

Laboratories 119

Laboratories Cell Biology Disease Research 119

Broad Institute

JUNE 4, 2025

Talk title coming soon By Nadya Karpova June 4, 2025 Talk title coming soon Lorin Crawford Microsoft Research New England (MSR) Add to calendar Talks Search - Any - Fall 2025 Spring 2025 Fall 2024 Spring 2024 Fall 2023 Spring 2023 Fall 2022 Spring 2022 Fall 2021 Spring 2021 Fall 2020 Spring 2020 Fall 2019 Spring 2019 Fall 2018 Spring 2018 Fall 2017 (..)

Research 40

Research 40

Drug Target Review

NOVEMBER 1, 2023

2 Implication of ATX in a large range of human diseases have been highlighted by both fundamental research and clinical trials. 1-5 Implication of ATX in a large range of human diseases have been highlighted by both fundamental research and clinical trials. He is a researcher at University of Oldenburg, Germany. 2018 Jun 13;5.

Clinical Trials 134

Clinical Trials Trials Small Molecule Disease 134

Elrig

MARCH 25, 2025

There will also be a poster award for early-career professionals recognising the research that the next generation of scientists bring to drug discovery. In addition, the conference comprises poster presentations, networking sessions, a vendor exhibition and a tour of AstraZenecas R&D centre.

RNA 59

RNA Bioinformatics Science Pharmacokinetics 59

SCIENMAG: Medicine & Health

JULY 12, 2023

A study examining unemployment and underemployment figures and suicide rates in Australia has found both were significant drivers of suicide mortality between 2004-2016.

Research 71

Research 71

Drug Target Review

MARCH 3, 2025

His research focuses on creating advanced cell culture models, such as brain organoids and assembloids, derived from patient-specific stem cells. In this interview, Professor Schwamborn discusses his research, the promise of brain organoids, and his vision for the future of stem cell-based therapies.

Disease 52

Disease Treatment Cell Biology Therapies 52

SCIENMAG: Medicine & Health

JUNE 8, 2023

Chilean policies aimed at reining in unhealthy food marketing are succeeding in protecting children from the onslaught of television advertisements (TV ads) for these products, according to new research.

Marketing 66

Marketing Regulations Production Research 66

Drug Target Review

FEBRUARY 8, 2024

Researchers from the Cleveland Clinic have identified changes in tumour-related bacteria, which have revealed possible new strategies to tackle the increase of young-onset colorectal cancer (CRC), which refers to CRC incidence in patients under 50 years old. 2016 February 7 [2024 January 6]; 22(5): 1736-44. Available from: [link]

Disease 105

Disease Research Drugs 105

SCIENMAG: Medicine & Health

JULY 25, 2023

Researchers from Mathematica studied high-performing Comprehensive Primary Care Plus (CPC+) sites to identify key strategies that contributed to significant reductions in acute hospitalization rates.

Hospitals 59

Hospitals Research 59

Drug Target Review

NOVEMBER 24, 2023

Researchers have explored systems that can deliver drugs directly to tumours in hope to reduce chemotherapy side effects. 2 Previously, La-Beck’s research has shown that liposomes made of phospholipids and cholesterol, like those used in patients, doubled tumour size in mice by suppressing their immune response in some tumours.

Immune Response 111

Immune Response Pharmacy Treatment Virus 111

The Pharma Data

JULY 3, 2025

Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of partnerships in women’s health, providing unparalleled insights into over 150 strategic deals executed globally between 2016 and 2025.

Licensing 40

Licensing Licensing Therapies Science 40

The Pharma Data

DECEMBER 3, 2020

3, 2020 — From 2012 to 2016, there was an increase in the percentage of Medicare beneficiaries on long-term dialysis who were aligned to an accountable care organization (ACO), with a reduction in spending seen for ACO-aligned beneficiaries, according to a study published online Nov. Professional. THURSDAY, Dec.

Research 52

Research Disease 52

Drug Target Review

APRIL 4, 2024

About the author Dr Nicholas Waters, Head of R&D, IRLAB Dr Nicholas Waters worked as a PhD student in Nobel Laureate Professor Arvid Carlsson’s research group at the Department of Pharmacology, Göteborg University (1987-1995). In 1998, he co-founded Carlsson Research. In 2013, Nicholas co-founded IRLAB Sweden.

Disease 105

Disease Treatment Licensing Licensing 105

Codon

APRIL 17, 2025

In 2016, researchers František Baluška and Stefano Mancuso suggested that ocelli could also explain Boquila ’s uncanny shape-shifting ability, positing that these “tiny eyes” may actually be capable of sight. Here is a time-lapse video of a plant moving in response to changing sunlight.)

Research 60

Research DNA Engineering Government 60

The Pharma Data

DECEMBER 23, 2020

23 2020 — From 2001 to 2016, out-of-pocket costs of evaluation and management (E/M) services and common diagnostic tests increased for neurology patients, according to a study published online Dec. respectively, for an MRI in 2016. WEDNESDAY, Dec. 23 in Neurology. Data were included for 3,724,342 patients. percent, respectively).

Research 52

Research 52

The Pharma Data

NOVEMBER 20, 2020

from the American Cancer Society in Atlanta, and colleagues estimated the LCS rate and growth at the national and state level between 2016 and 2018 using data from the American College of Radiology Lung Cancer Screening Registry. The researchers found that nationally, the screening rate was steady between 2016 (3.3 Fedewa, Ph.D.,

Research 52

Research 52

The Pharma Data

DECEMBER 24, 2020

24, 2020 — Rising out-of-pocket costs for neurological tests could lead many Americans to forgo them, researchers warn. The researchers also found an increase in patients who paid out-of-pocket costs for tests. For example, the percentage of patients who had out-of-pocket payments for MRIs rose from 24% in 2001 to 70% in 2016.

Research 52

Research 52

Conversations in Drug Development Trends

APRIL 4, 2024

To help integrate these various regulatory standards, the International Council for Harmonization (ICH) of Technical Requirements for Pharmaceuticals for Human Use was founded in 2016. Since reaching full implementation on January 21, 2023, numerous regulatory bodies have adopted the ICH M10 standards.

Small Molecule 80

Small Molecule Clinical Trials Pharmaceuticals Pharmaceutical Companies 80

Drug Target Review

OCTOBER 11, 2023

Autophagy in a hot topic in scientific circles; the number of papers that mention the process has risen almost exponentially since Yoshinori Ohsumi was awarded the Nobel Prize in 2016 for his research into its underlying mechanisms. The building blocks to make rare disease treatments more common | Research and Innovation [Internet].

Disease 113

Disease Treatment Small Molecule Therapies 113

Drug Target Review

JUNE 5, 2025

Since 2007 he has held senior positions in the medical device industry, managing a wide range of business units including: US sales and marketing, research and development, quality& regulatory, scientific, and medical affairs and market access. Published March 2016. References Mangla A, Ehsan M, Agarwal N, et al. Transfus Sci.

Disease 52

Disease Treatment Therapies Nurses 52

The Pharma Data

OCTOBER 23, 2020

23, 2020 — Vaccination coverage with many recommended vaccines is high by age 24 months, according to research published in the Oct. from the CDC in Atlanta, and colleagues used data from the National Immunization Survey-Child to estimate vaccination coverage among children born in 2016 to 2017. FRIDAY, Oct. 23 issue of the U.S.

Vaccine 52

Vaccine Disease Research 52

FDA Law Blog: Biosimilars

MARCH 10, 2024

Likely discussion topics during the session will address what has changed since 2016 when FDA/HHS and DEA concluded that cannabis remain in schedule I, why DEA may be required under U.S. Houck will participate in a session entitled “Marijuana Rescheduling: Exploring FDA’s Recommendation, Stakeholder Impact, and Broader Implications.”

Regulations 64

Regulations FDA Production Drugs 64

Advarra

DECEMBER 1, 2022

In the past several years, Health and Human Services (HHS) Office of Human Research Protections (OHRP), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) have announced and/or implemented new regulations to address the challenges of conducting clinical trials involving multiple research sites.

Regulations 52

Regulations Compliance FDA Clinical Trials 52

Drug Target Review

APRIL 7, 2025

Silver Spring (MD): Food and Drug Administration (US); 2016-. About the author Dr Cyril Clarke, Vice President, Therapeutic Area, GMI Drug Development and Consulting, ICON Biotech Clarke is a clinical pharmacologist with over 30 years experience in clinical research; seventeen of which are within industrial clinical pharmacology.

Clinical Development 69

Clinical Development Clinical Trials Clinical Pharmacology Trials 69

Broad Institute

MARCH 8, 2024

On average, biomedical researchers do not receive their first major grant until the age of 43. Support The Next Generation Awards have strengthened Boston’s biomedical ecosystem by bolstering the careers of emerging scientists, helping them launch their own labs and develop as leaders in the research community.

Research 52

Research 52

New Drug Approvals

MARCH 26, 2025

Bavtavirine can be used for HIV disease research. 2016-06-30. ////////////Bavtavirine Bavtavirine is a potent non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bavtavirine is part of highly active antitiretroviral therapy (HAART) treatment regimen. SCHEME PATENT WO2016105564 [link] A mixture of compound 2a (100 mg, 0.30

Organic Chemistry 62

Organic Chemistry Science Therapies Treatment 62

New Drug Approvals

NOVEMBER 13, 2023

Vodobatinib can be used for chronic myeloid leukemia (CML) research. Vodobatinib can be used for chronic myeloid leukemia (CML) research [1] [2]. VODOBATINIB 1388803-90-4 Molecular Weight 453.92 Vodobatinib exhibits activity against most BCR-ABL1 point mutants, and has no activity against BCR-ABL1T315I.

Treatment 62

Treatment Disease Therapies Production 62

Drug Target Review

SEPTEMBER 26, 2023

Human derived induced pluripotent stem cells (hiPSCs) have revolutionised research and are increasingly used for toxicology screening and disease modelling. 27,28 Since the advent of hiPSC technology almost two decades ago enormous progress has been made in many areas of research. 2016 Sep 1;81:15–20. 2016 Jan 15;96:253–73.

Drugs 111

Drugs FDA Disease Animal Testing 111

Eye on FDA

OCTOBER 19, 2022

Tik Tok was first released in 2016. Earlier research, the agency says, shows that different types of endorsers have different levels of influence, with physicians coming in highest and celebrities coming in lowest. As noted in a recent posting , FDA research has been largely focused on traditional media platforms.

FDA 89

FDA Regulations Research Production 89

Broad Institute

SEPTEMBER 15, 2023

TBD By lcopelan@broadinstitute.org September 15, 2023 Alex Lu Microsoft Research New England MIA About Current Schedule Video Playlist Resources All talks Contact us MIA Talks Search - Any - Fall 2023 Spring 2023 Spring 2024 Fall 2022 Spring 2022 Fall 2021 Spring 2021 Fall 2020 Spring 2020 Fall 2019 Spring 2019 Fall 2018 Spring 2018 Fall 2017 Spring (..)

Research 40

Research 40

Drug Target Review

JULY 4, 2023

The drivers behind the demand for ADCs Providing more targeted therapeutic options in the oncology space has underpinned the rapid growth of the ADC market; between 2016 to 2020, the US ADC market grew by 45 percent to a value of nearly $1.5 Antibody drug conjugated with cytotoxic payload.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

Conversations in Drug Development Trends

AUGUST 5, 2024

Role at Worldwide: Associate Director of Project Management/Global Project Lead Joined Worldwide: September 2016 LinkedIn: Margo A Smith Get to Know Margo through this Q&A What attracted you to Worldwide and what keeps you here? What attracted me to Worldwide was its stellar reputation in the CNS research community.

Clinical Trials 52

Clinical Trials Trials Disease Marketing 52

Common Sense for Drug Policy Blog

DECEMBER 16, 2023

Thousands of years of knowledge from traditional medicine practices outlined the dose, efficacy, and preparation of many natural medicines and have demonstrated that entheogens are a powerful tool for healing various conditions ( Yuan, Ma, Ye, & Piao, 2016 ). Willingness to participate in entheogen use research in naturalistic settings.

Research 52

Research 52